TD Cowen analyst Andrew Kligerman lowered the firm’s price target on Berkshire Hathaway (BRK.B) to $479 from $485 and keeps a Hold rating on the shares. The firm revised its 2025/2026 estimates.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRK.B:
- UnitedHealth price target raised to $325 from $290 at BofA
- Semper Augustus Boosts Stake in Berkshire Hathaway B
- Bill & Melinda Gates Foundation Trust Boosts Berkshire Hathaway B Stake
- Chilton Investment Co LLC Reduces Stake in Berkshire Hathaway B
- Graham Capital Management Boosts Stake in Berkshire Hathaway